3,3',5-triiodothyroacetic acid has been researched along with Hyperlipemia in 2 studies
tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MECIANI, L | 1 |
| BRINA, A | 1 |
| RUEGAMER, WR | 1 |
2 other studies available for 3,3',5-triiodothyroacetic acid and Hyperlipemia
| Article | Year |
|---|---|
[POSSIBILITIES AND LIMITATIONS OF THE AMBULATORY TREATMENT OF DISLIPIDEMIA IN CORONARY DISEASE PATIENTS WITH TRIAC (TRIIODOTHYROACETIC ACID). II.USE OF TRIAC ASSOCIATED WITH VITAMIN A AND DIVANILLIDENE-CYCLOHEXANONE (D.V.C.E.)].
Topics: Aged; Cholesterol; Coronary Disease; Cyclohexanones; Drug Therapy; Humans; Hyperlipidemias; Lipids; | 1964 |
3,5 DIIODOTHYROACETIC ACID MOBILIZATION OF RAT LIVER LIPID AND RELATIVE TOXICITY OF ORAL TRIAC AND TRIPROP.
Topics: Acetates; Bile Acids and Salts; Cholesterol; Dietary Fats; Diiodothyronines; Hyperlipidemias; Lipid | 1965 |